The number of people with susceptibility test result for rifampicin in Iraq
Iraq: The number of people with susceptibility test result for rifampicin was 29.8 in 2021. ◆ Volatile
Latest (2021)
29.8
Change on year
up 350.3%
World rank
133rd
of 146 countries
All-time high
100
in 2018
All-time low
6.62
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Iraq, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Iraq recorded 29.8 for the number of people with susceptibility test result for rifampicin in 2021.
Compared with earlier readings it is up 350.3% on the previous year and down 70.0% over five years.
Iraq ranks 133rd of 146 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Iraq, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 99.38 | — |
| 2018 | 100 | +0.6% |
| 2019 | 69.2 | -30.8% |
| 2020 | 6.62 | -90.4% |
| 2021 | 29.8 | +350.3% |
Iraq compared with similar countries
- Iraq's 29.8 is below the median for upper middle income countries, which is 92.7, 32% of the median. (45 countries reporting)
- Iraq's 29.8 is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 89, 33% of the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 89.53 | 69.2 | 100 | 3 |
| 2020s | 18.21 | 6.62 | 29.8 | 2 |
Countries ranked near Iraq
More health data for Iraq
- Un projection of annual infant deaths, annual growth rate -1.4 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9773 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 898.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5,830 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.988 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0587 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9818 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Iraq?
- The number of people with susceptibility test result for rifampicin in Iraq was 29.8 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Iraq?
- The highest recorded value was 100 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Iraq?
- The lowest recorded value was 6.62 in 2020.
- How does Iraq rank for the number of people with susceptibility test result for rifampicin?
- Iraq ranks 133rd out of 146 countries with data for 2021.
- Where does this Iraq data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).